Defects in Regulatory T Cells Due to CD28 Deficiency Induce a Qualitative Change of Allogeneic Immune Response in Chronic Graft-versus-Host Disease

被引:5
作者
Akieda, Yuki [1 ]
Wakamatsu, Ei [1 ]
Nakamura, Tomoe [1 ]
Ishida, Yasuo [2 ]
Ogawa, Shuhei [1 ]
Abe, Ryo [1 ]
机构
[1] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan
[2] Teikyo Univ, Chiba Med Ctr, Dept Pathol, Chiba 2990111, Japan
关键词
MAJOR HISTOCOMPATIBILITY COMPLEX; CONSENSUS DEVELOPMENT PROJECT; PHOSPHATIDYLINOSITOL; 3-KINASE; CYTOPLASMIC DOMAIN; NEPHROTIC SYNDROME; CLINICAL-TRIALS; B-CELLS; ACTIVATION; RAPAMYCIN; MODEL;
D O I
10.4049/jimmunol.1402591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In patients receiving allogeneic hematopoietic cell transplantation, chronic graft-versus-host disease (cGVHD) remains a frequent complication and resembles autoimmune diseases such as systemic lupus erythematosus and systemic sclerosis. Our previous work demonstrated the critical role of CD28 costimulation of donor T cells for GVHD induction. In this study, we investigate the role of CD28 costimulation of host T cells in cGVHD. CD28-intact mice as hosts showed systemic lupus erythematosus-type cGVHD, whereas CD28-deficient mice developed a distinct phenotype of cGVHD, with fibrotic damage in skin and internal organs, resembling systemic sclerosis. This phenotype was due to a lack of signaling through the C-terminal proline-rich motif within host CD28's cytoplasmic tail, a motif previously shown to be required for development of regulatory T cells (Tregs) and function of conventional T cells. Adoptive transfer experiments demonstrated that a defect in host CD4(+)CD25(+)Tregs, but not in conventional T cells, was responsible for disease phenotype. Host Treg deficiency altered the cytokine pattern of donor CD4(+) T cells and the Ag specificity of autoantibodies, and these might lead to phenotypic change. Thus, host CD28 signaling controlled the pathogenesis of cGVHD through effects on host Tregs, whose status impacts qualitatively on the allogeneic immune responses.
引用
收藏
页码:4162 / 4174
页数:13
相关论文
共 50 条
  • [31] Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents
    Wiegering, Verena
    Keupp, Anne
    Frietsch, Marieke
    Fiessler, Cornelia
    Haas, Kirsten
    Haubitz, Imme
    Beyersdore, Nildas
    Wolff, Matthias
    Schlegel, Paul-Gerhardt
    Eyrich, Matthias
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (05) : E133 - E137
  • [32] Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease
    Santos e Sousa, Pedro
    Cire, Severine
    Conlan, Thomas
    Jardine, Laura
    Tkacz, Claire
    Ferrer, Ivana R.
    Lomas, Cara
    Ward, Sophie
    West, Heather
    Dertschnig, Simone
    Blobner, Sven
    Means, Terry K.
    Henderson, Stephen
    Kaplan, Daniel H.
    Collin, Matthew
    Plagnol, Vincent
    Bennett, Clare L.
    Chakraverty, Ronjon
    JCI INSIGHT, 2018, 3 (05)
  • [33] Activation-associated phenotype of CD3+ T cells in acute graft-versus-host disease
    Morante, M. Paz
    Briones, J.
    Canto, E.
    Sabzevari, H.
    Martino, R.
    Sierra, J.
    Rodriguez-Sanchez, J. L.
    Vidal, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (01) : 36 - 43
  • [34] Alloantigen-specific regulatory T cells prevent experimental chronic graft-versus-host disease by simultaneous control of allo- and autoreactivity
    Sagoo, Pervinder
    Ratnasothy, Kulachelvy
    Tsang, Yuen
    Barber, Linda D.
    Noble, Alistair
    Lechler, Robert I.
    Lombardi, Giovanna
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (12) : 3322 - 3333
  • [35] Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease
    Kuzmina, Zoya
    Greinix, Hildegard T.
    Knobler, Robert
    Worel, Nina
    Kouba, Michal
    Weigl, Roman
    Koermoeczi, Ulrike
    Rottal, Arno
    Pohlreich, David
    Zielinski, Christoph
    Pickl, Winfried F.
    BLOOD, 2009, 114 (03) : 744 - 746
  • [36] ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells
    Griesenauer, Brad
    Jiang, Hua
    Yang, Jinfeng
    Zhang, Jilu
    Ramadan, Abdulraouf M.
    Egbosiuba, Jane
    Campa, Khaled
    Paczesny, Sophie
    JOURNAL OF IMMUNOLOGY, 2019, 202 (10) : 3053 - 3064
  • [37] Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease
    Doanh Le Huu
    Matsushita, Takashi
    Jin, Guihua
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    Takehara, Kazuhiko
    Tedder, Thomas F.
    Fujimoto, Manabu
    BLOOD, 2013, 121 (16) : 3274 - 3283
  • [38] Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease
    Hippen, K. L.
    Merkel, S. C.
    Schirm, D. K.
    Nelson, C.
    Tennis, N. C.
    Riley, J. L.
    June, C. H.
    Miller, J. S.
    Wagner, J. E.
    Blazar, B. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (06) : 1148 - 1157
  • [39] Therapeutic Potential of Induced and Natural FoxP3+ Regulatory T Cells for the Treatment of Graft-Versus-Host Disease
    Prinz, Immo
    Koenecke, Christian
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2012, 60 (03) : 183 - 190
  • [40] Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease
    Hannon, Muriel
    Lechanteur, Chantal
    Lucas, Sophie
    Somja, Joan
    Seidel, Laurence
    Belle, Ludovic
    Bruck, France
    Baudoux, Etienne
    Giet, Olivier
    Chantillon, Anne-Marie
    Delvenne, Philippe
    Drion, Pierre
    Beguin, Yves
    Humblet-Baron, Stephanie
    Baron, Frederic
    TRANSFUSION, 2014, 54 (02) : 353 - 363